4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-22-026163
Director acquired 9 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BARASCH RICHARD A Director | 2022-10-05 | Other acquisition | +1 | 142,019 | D | ||
| BARASCH RICHARD A Director | 2022-10-05 | Other acquisition | +8 | 8 | I | ||
| Derivatives | |||||||
| BARASCH RICHARD A Director | 2022-10-05 | Other acquisition · Series A Common Stock Equivalent Convertible Preferred Stock | +1,595 | 1,595 | D | ||
| BARASCH RICHARD A Director | 2022-10-05 | Other acquisition · Earnout rights (Series A Common Stock Equiv Conv Preferred) | +230 | 230 | D | ||
| BARASCH RICHARD A Director | 2022-10-05 | Other acquisition · Series A Common Stock Equivalent Convertible Preferred Stock | +6,204 | 6,204 | I | ||
| BARASCH RICHARD A Director | 2022-10-05 | Other acquisition · Earnout rights (Series A Common Stock Equiv Conv Preferred) | +894 | 894 | I | ||
| BARASCH RICHARD A Director | 2022-10-05 | Other acquisition · Private Placement Warrants | +548,503 | 548,503 | D | ||
| BARASCH RICHARD A Director | 2022-10-05 | Other acquisition · Earnout rights (Private placement warrants) | +73,024 | 73,024 | D | ||
Loading xslF345X03/wf-form4_166517567146567.xml…